XTalks

MARCH 19, 2025

This week, were celebrating a significant milestone: the release of our 200th episode of the Xtalks Life Science Podcast ! We’re excited to continue our journey by bringing you more in-depth conversations with industry leaders, highlighting the innovations and trends that shape the future of life sciences.

Life Science 52

Life Science Branding Clinical Trials Clinical Trials 52

Pharmaceutical Technology

DECEMBER 14, 2022

GSK has entered a strategic partnership with Wave Life Sciences to progress the discovery and development of oligonucleotide therapies for new genetic targets. Wave will conduct all preclinical research for the programmes of both companies until investigational new drug (IND)-facilitating studies. .

Life Science 162

Life Science Development Gene Therapy Genetics 162

Pharmaceutical Technology

SEPTEMBER 15, 2022

From the Human Genome Project to contemporary drug development, collaboration is critical to the life sciences. It is also an important factor in the success of life sciences clusters, where a high concentration of pharmaceutical or medical device companies can all be found in one district, city or region.

Life Science 130

Life Science Drug Delivery Genome Project Development 130

Pharmaceutical Technology

OCTOBER 28, 2022

Drug discovery and development is an incredibly expensive and time-consuming process, taking between 12 and 18 years, and costing on average between $2 billion and $3 billion. Robots can improve drug discovery and development. Remote-controlled robotic labs.

Development 311

Development Drugs Pharma Companies Life Science 311

pharmaphorum

JANUARY 25, 2024

Discover the role of GenAI in life sciences in 2024. Explore how artificial intelligence and machine learning techniques like GenAI are revolutionising drug development, diagnostics, and research. Learn how industry leaders, including Google, are leveraging GenAI to advance healthcare and enhance patient outcomes.

Life Science 115

Life Science Development Drugs Research 115

Pharmaceutical Technology

JUNE 2, 2023

Anavex Life Sciences has secured new US intellectual property compositions patent for its ANAVEX 2-73 (blarcamesine). Anavex’s orally available drug candidate restores cellular homeostasis by targeting sigma-1 and M1 muscarinic receptors.

Life Science 130

Life Science Clinical Trials Clinical Trials Trials 130

Pharmaceutical Technology

FEBRUARY 13, 2025

Wide areas of the pharmaceutical industry are ripe for enhancement, as examples from the industrys top innovators reflect.

Life Science 147

Life Science Drugs 147

Pharmaceutical Technology

JUNE 16, 2023

for an undisclosed sum, boosting its life science AI capabilities. The deal enables Verix to further improve its capacities to use AI to advance the brand growth of life science companies. Artificial intelligence (AI)-driven commercial optimisation platform provider Verix has purchased start-up.ai start-up.ai

Life Science 130

Life Science Engineer Branding Marketing 130

Bio Pharma Dive

AUGUST 17, 2021

Bain Capital's latest life sciences fund, its third, is another example of private equity's growing interest in drug development.

Life Science 256

Life Science Development Drugs 256

Bio Pharma Dive

MAY 15, 2024

Elsewhere, ICER is raising questions about a PTSD drug and BioMarin is cut jobs after a pipeline review. The parent of Novo Nordisk is acquiring 60% ownership of Single Use Support.

Life Science 164

Life Science Drugs 164

Bio Pharma Dive

MAY 26, 2022

Bosley, who once led the CRISPR gene editing biotech, will become a venture partner at Advent Life Sciences, which backs a range of early-stage drug companies.

Gene Editing 256

Gene Editing Life Science Gene Drugs 256

XTalks

JANUARY 31, 2024

Skye Bioscience is at the forefront of exploring the endocannabinoid system for drug development. Punit Dhillon, Chairman & CEO Skye Bioscience Punit brings two decades of experience as a leader and investor within the life sciences sector. Subscribe to the Xtalks Life Science Podcast to never miss a new episode.

Life Science 116

Life Science Development Drugs Medicine 116

XTalks

SEPTEMBER 12, 2023

Life science podcasts have emerged as an invaluable tool for building connections with audiences in the digital era. Furthermore, we’ll explore the unique advertising opportunities that this platform offers, positioning brands at the forefront of the life science industry. The result?

Life Science 105

Life Science Branding Clinical Trials Clinical Trials 105

pharmaphorum

FEBRUARY 29, 2024

Explore the impact of the Inflation Reduction Act (IRA) on drug prices and negotiations within the life sciences industry, as it stands on the threshold of change. Gain insights into the potential outcomes and implications of this legislation.

Life Science 113

Life Science Drugs 113

XTalks

DECEMBER 20, 2023

As we step into 2024, the life sciences continue to evolve at an unprecedented pace, driven by technological innovation, a deeper understanding of human biology and the application of new technologies in areas like drug development and health wearables.

Life Science 119

Life Science Gene Editing Development Clinical Trials 119

XTalks

SEPTEMBER 6, 2023

David Young, founder and President R&D at Processa Pharmaceuticals, a clinical-stage pharmaceutical company developing personalized approaches to cancer treatments with a focus on next generation chemotherapy drugs with improved safety and efficacy. Subscribe to the Xtalks Life Science Podcast to never miss a new episode.

Life Science 116

Life Science Drugs Development Research 116

AuroBlog - Aurous Healthcare Clinical Trials blog

JANUARY 9, 2024

Experts in the life-sciences industry are of the view that doing away with human studies for new drugs in India is unscientific and risky as patients here have different anthropometry.

Trials 185

Trials Life Science Clinical Trials Clinical Trials 185

Bio Pharma Dive

FEBRUARY 6, 2024

The life sciences investor has backed a number of startups working on technologies for delivering and manufacturing cell and gene medicines.

Drug Delivery 202

Drug Delivery Life Science Gene Manufacturing 202

XTalks

MARCH 20, 2024

In this featured episode of Xtalks People in Life Sciences, Ayesha spoke with Ashish Jain, Senior Director of Clinical Safety and Pharmacovigilance (PV) at Curis , a pioneering biotech company specializing in cutting-edge cancer therapies. Subscribe to the Xtalks Life Science Podcast to never miss a new episode.

Life Science 113

Life Science Development Drugs 113

Bio Pharma Dive

NOVEMBER 7, 2022

The generics company is acquiring Oyster Point Pharma and the privately held Famy Life Sciences in a move aimed at creating an ophthalmology business.

Life Science 198

Life Science Development Drugs 198

Drug Channels

MARCH 18, 2024

Informa Connect’s Life Sciences Pricing & Contracting USA May 21-23, 2024 | New Orleans Drug Channels readers save 10% with code 24DRCH10* Whether your daily focus is on Medicaid, Government Pricing, 340B, Drug Price Transparency, Commercial Contracting or Chargebacks , we have you covered! All rights reserved.

Life Science 98

Life Science Regulation Drugs 98

XTalks

DECEMBER 4, 2024

In this episode, Ayesha spoke with John Yu, MD, CEO of Kairos Pharma , a company advancing therapies to overcome challenges in cancer drug resistance and immune suppression. Kairos is developing therapeutics that reverse cancer drug resistance in cancers such as prostate and lung cancer. Dr. Yu has also led numerous clinical trials.

Drugs 59

Drugs Life Science Clinical Trials Clinical Trials 59

Pharmaceutical Technology

SEPTEMBER 6, 2024

German life science company Evotec has announced a collaboration with X-Chem to accelerate early-stage drug discovery-leveraging technology.

Life Science 130

Life Science Drugs 130

Pharmaceutical Technology

MARCH 2, 2023

The growth in sales was driven by all regions and business sectors, particularly Life Science. to €10.38bn in its Life Science business during the year. The EBITDA pre of Life Science grew by 14.4% Merck’s immuno-oncology drug Bavencio increased by 57.9% in group sales in fiscal 2022. organic rise.

Sales 245

Sales Life Science Licensing Licensing 245

XTalks

NOVEMBER 6, 2024

Gelteq centers its technology on a proprietary, customizable gel platform designed for precise drug delivery, supporting prescription drugs, nutraceuticals, pet care and sports supplements. Across the industry, recent innovations in drug delivery signal a creative shift towards ease of administration and expanded treatment options.

Drug Delivery 104

Drug Delivery Drugs Bioequivalency Bioavailability 104

pharmaphorum

MARCH 6, 2025

In a new pharmaphorum podcast, web editor Nicole Raleigh speaks with Bryan Hill, life sciences chief technology officer at Cognizant, in a conversation on how generative AI is revolutionising life sciences and drug development.

Life Science 100

Life Science Development Drugs 100

XTalks

MARCH 14, 2025

Novo Nordisks investigational obesity combination drug, CagriSema (a fixed dose combination of cagrilintide 2.4 Novo shared the latest data from the Phase III REDEFINE 2 trial evaluating the drug in overweight or obese patients with type 2 diabetes. mg and semaglutide 2.4 after 68 weeks compared to 3.1% with placebo. with placebo.

Trials 89

Trials Drugs Clinical Trials Clinical Trials 89

Pharma Times

NOVEMBER 7, 2024

New initiatives to tackle AI-related challenges in life sciences

Life Science 144

Life Science Drugs 144

XTalks

JUNE 12, 2024

Precision dosing, also known as personalized dosing, aims to tailor drug dosages to the individual characteristics of each patient to achieve optimal therapeutic outcomes while minimizing adverse effects. Subscribe to the Xtalks Life Science Podcast to never miss a new episode.

Life Science 97

Life Science Pharmacy Doctor Doctors 97

Bio Pharma Dive

JANUARY 23, 2024

J&J and Bristol Myers joined the latest funding round for the startup, which was led by the newly launched Mirae Asset Capital Life Science.

RNA 164

RNA Life Science Drugs 164

Drug Discovery World podcast

MARCH 20, 2025

This is the latest episode of the free DDW narrated podcast, titled Critical tools that support drug discovery and development, which covers two articles written for DDW Volume 24 Issue 3, Summer 2023.They and Big data: Charting a new path to drug discovery and development .

Development 52

Development Life Science Drugs Big Data 52

XTalks

JANUARY 17, 2025

Related: Intra-Cellulars Schizophrenia Drug Caplyta Shows Promising Trial Results for Relapse Prevention Offered as a simplified once-daily dosing regimen, patients can begin treatment at the effective dose without the need for gradual escalation.

Drugs 105

Drugs Trials Sales Life Science 105

XTalks

NOVEMBER 12, 2024

World Pneumonia Day 2024 provides an opportunity to examine the latest advances in pneumonia treatment and prevention — and the role that healthcare and life sciences industries play in reducing its global impact. These innovations can help prevent viral pneumonia complications in high-risk groups.

Bacteria 110

Bacteria Life Science Vaccination Vaccine 110

Pharmaceutical Technology

JUNE 6, 2023

Led by Bain Capital Life Sciences, the financing round has also seen participation from Sofinnova Investments, TCGX and Wellington Management. The therapy has also received orphan drug designation and breakthrough therapy designation from the US Food and Drug Administration.

Genetics 279

Genetics Life Science Trials Clinical Development 279

Drug Channels

MARCH 28, 2024

Read more » © 2006-2024 HMP Omnimedia, LLC d/b/a Drug Channels Institute , an HMP Global Company. Bill discusses specialty therapy access barriers, including payer utilization management techniques and “no coverage” policies. Contact Mercalis to learn about their Patient Support Services. Read on for Bill’s insights. All rights reserved.

Life Science 98

Life Science Marketing Production Development 98

XTalks

SEPTEMBER 13, 2023

The drug is the only natural THC-based investigational drug undergoing FDA trials. Subscribe to the Xtalks Life Science Podcast to never miss a new episode. Ram and Claudia spoke about the compound, including clinical data from the ongoing trials evaluating it.

Life Science 110

Life Science Trials Compliance Engineer 110

Pharmaceutical Technology

JANUARY 30, 2023

The forecast branded NHS drug sales growth figure for 2023 was adjusted to 5.63%. for 2023), and members lose the opportunity to consult directly with the government on key aspects of life science policy or to negotiate directly on the terms of the payback scheme. In 2022, a proposed payback figure of 19.1%

Sales 243

Sales Branding Drugs Medicine 243